Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy

Antivir Ther. 2005:10 Suppl 2:M91-9.

Abstract

Background: Damage to mitochondria (mt) is a major side effect of highly active antiretroviral therapy (HAART) that includes a nucleoside reverse transcriptase inhibitor (NRTI). Such damage is associated with the onset of lipodystrophy in HAART-treated HIV+ patients. To further investigate mt changes during this syndrome, we analysed the expression of mtRNA in adipocytes from lipodystrophic HIV+ patients taking NRTI-containing HAART and compared it with similar cells from healthy individuals.

Materials and methods: Total RNA was extracted from adipocytes collected from different anatomical locations of 11 HIV+ lipodystrophic patients and seven healthy control individuals. RNA was reverse transcribed and Taqman-based real-time PCR was used to quantify three different mt transcripts (ND1, CYTB and ND6 gene products). mtRNA content was normalized versus the housekeeping transcript L13.

Results: ND1, CYTB and ND6 expression was significantly reduced in HIV+ lipodystrophic patients. HIV+ men and women did not differ in a statistically significant way regarding the levels of ND1 and ND6, whereas the opposite occurred for CYTB.

Conclusions: Lipodystrophy following treatment with NRTI-containing HAART is associated with a decrease in adipose tissue mtRNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / metabolism*
  • Adult
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Base Sequence
  • DNA, Mitochondrial / analysis
  • Female
  • HIV Infections / drug therapy*
  • HIV-Associated Lipodystrophy Syndrome / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • RNA / biosynthesis*
  • RNA, Mitochondrial
  • Reverse Transcriptase Inhibitors / adverse effects*
  • Transcription, Genetic

Substances

  • DNA, Mitochondrial
  • RNA, Mitochondrial
  • Reverse Transcriptase Inhibitors
  • RNA